Sort
141,003 grants matching “cytokine”
Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users
$715,709Sylvia Fitting · Univ Of North Carolina Chapel Hill · R01 · FY2023 · DA
Dopamine function, inflammation and connectivity in PTSD
$715,697James Douglas Bremner · Emory University · R01 · FY2022 · MH
URINARY SCHISTOSOMIASIS: INFECTION AND DISEASE
$715,657Case Western Reserve University · U01 · FY2003 · AI
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
$715,641Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Amyloid Beta CAR Macrophages: a cell engineering strategy to clear pathogenic proteins
$715,640Saar Gill · University Of Pennsylvania · R01 · FY2024 · NS
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$715,549Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Clinical trials employing cancer vaccine combination therapies
$715,531James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Interruption of maternal-fetal transmission of HIV
$715,530Joseph M McCune · University Of California, San Francisco · R01 · FY2012 · AI
T helper cells and stem cells in colon homeostasis and tumor initiation
$715,501Arnold Han · Columbia University Health Sciences · R01 · FY2025 · DK
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
$715,495Adriana Weinberg · University Of Colorado Denver · U01 · FY2020 · AI
Inflammatory stressors in serotonergic brainstem dysfunction and SIDS
$715,459Robin Lynn Haynes · Boston Children'S Hospital · R01 · FY2024 · HD
Cannabis use, PrEP and HIV transmission risk Among Black MSM in Chicago
$715,456Dustin T Duncan · Columbia University Health Sciences · R01 · FY2024 · DA
Methamphetamine Activation of Inflammasome and Altered immunity in HIV (MAIA) Study
$715,455Susan Pereira Ribeiro · Emory University · R01 · FY2025 · DA
PET Detection of CCR2 in Human Atherosclerosis
$715,437Robert J Gropler · Washington University · R01 · FY2024 · HL
Stress Exposure and Immune Outcomes in Children
$715,408Thomas G O'Connor · University Of Rochester · R01 · FY2015 · MH
Regulation of NF-Kappa B
$715,263Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2011 · AI
Alzheimer's disease drug development
$715,227Nigel H. Greig · National Institute On Aging · ZIA · FY2023 · AG
Validated Immunoassays to Accelerate Therapeutic Genome Editing INDs
$715,222Alice F Tarantal · University Of California At Davis · U01 · FY2025 · AI
Novel ROCK inhibitors for COPD
$715,216Jurg Pfister · Theratrophix, Llc · R44 · FY2015 · HL
Neuroprotection by IFN-beta in AIDS
$715,213Marcus Kaul · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · MH
Role of IKK alpha in lung cancer development
$715,207Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Innate Immune Activation and Endothelial Cell Dysfunction in Acute Kawasaki Disease
$715,175Jane C Burns · University Of California, San Diego · R01 · FY2018 · HL
Development of a Fully Humanized Antibody for Treating Lung Emphysema
$715,140Douglas W.p. Hay · Allinaire Therapeutics, Llc · R44 · FY2017 · HL
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection
$715,124Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2020 · AI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal
$715,074Trevor J. Orchard · University Of Pittsburgh At Pittsburgh · R37 · FY2010 · DK